Your browser doesn't support javascript.
loading
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancer.
Han, Yuyan; Zhang, Mutian; Xu, Junfeng; Li, Jia; Xu, Yifan; Thompson, Timothy C; Logothetis, Christopher J; Sun, Deqiang; Gu, Jian.
Affiliation
  • Han Y; Department of Epidemiology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.
  • Zhang M; School of Biological Sciences, University of Northern Colorado Greeley, CO 80639, USA.
  • Xu J; Institute of Biosciences & Technology, Texas A & M University Houston, TX 77030, USA.
  • Li J; Department of Epidemiology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.
  • Xu Y; Institute of Biosciences & Technology, Texas A & M University Houston, TX 77030, USA.
  • Thompson TC; Department of Epidemiology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.
  • Logothetis CJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.
  • Sun D; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center Houston, TX 77030, USA.
  • Gu J; Institute of Biosciences & Technology, Texas A & M University Houston, TX 77030, USA.
Am J Cancer Res ; 11(3): 968-978, 2021.
Article in En | MEDLINE | ID: mdl-33791167

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Am J Cancer Res Year: 2021 Document type: Article Affiliation country: